Complicated Skin and Skin Structure Infections

Study identifier:3591IL/0079

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Multicenter, Randomized, Double blind, Comparative trial of intravenous MERREM (Meropenem, ICI 194,660) vs PRIMAXIN I.V. (imipenem-cilastatin) in the treatment of hospitalised subjects with complicated skin and skin structure infections.

Medical condition

Skin Infection, Abscess

Phase

Phase 3

Healthy volunteers

No

Study drug

Meropenem, Imipenem-cilastatin

Sex

All

Actual Enrollment

1000

Study type

Interventional

Age

13 Years +

Date

Study Start Date: 01 Feb 2001
Primary Completion Date: 01 Dec 2003
Study Completion Date: 01 Apr 2004

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria